Preventive cardiology as new subspecialty of cardiovascular medicine.

Transactions of the American Clinical and Climatological Association(2020)

引用 2|浏览15
暂无评分
摘要
Although management of ischemic cardiovascular disease has improved by leaps and bounds and significantly reduced the risk of mortality from a heart attack relative to decades past, the life trajectory of the average person (with stress, poor diet, excess body weight, inactivity, smoking, exposure to pollutants, poor management of metabolic comorbidities, etc.) still leads straight to development of this disease. Therefore, we have an unprecedented opportunity to focus on prevention of atherosclerosis before cardiovascular events occur, an endeavor that needs expert intervention with cardiovascular risk assessment, risk factor management, lifestyle counseling, dietary interventions, use of natural supplements, and pharmacotherapy. It is time for the budding specialty of preventive cardiology to come to the fore, from the historic background of fragmented clinical services such as lipid, hypertension, diabetes, endocrine, and cardiology clinics. Many patients need this specialized service, which cannot be provided anywhere else but in a dedicated practice well integrated with all other hospital services. Here we discuss the origin of preventive cardiology, the organization and core competencies required for excellence in this medical art, and the structure for education and fellowship training for professional recognition and board certification.
更多
查看译文
关键词
CVD risk assessment,PCSK9,Preventive cardiology,atherosclerotic cardiovascular disease (ASCVD),diabetes,hypercholesterolemia,hypertension,lipid clinic,lipid-lowering agents,medical subspecialty,statins
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要